Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle D Liedtke

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Safety|January 26, 2010
Drug interactions with antiretrovirals and warfarinMichelle D Liedtke, R Chris Rathbun
Pharmaceutics|December 7, 2013
Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for managementR Chris Rathbun, Michelle D Liedtke
The Annals of Pharmacotherapy|February 7, 2009
Warfarin-antiretroviral interactionsMichelle D Liedtke, R Chris Rathbun
The Annals of Pharmacotherapy|November 2, 2012
A probable interaction between warfarin and the antiretroviral TRIO study regimenMichelle D Liedtke, Amulya Vanguri, R Chris Rathbun
The Annals of Pharmacotherapy|February 19, 2004
Anticonvulsant and antiretroviral interactionsMichelle D Liedtke, Staci M Lockhart, R Chris Rathbun
International Journal of STD & AIDS|June 21, 2017
Evaluation of the concurrent use of dolutegravir and metformin in human immunodeficiency virus-infected patientsAnne Masich, Melissa E Badowski, Michelle D Liedtke, et al.
The Annals of Pharmacotherapy|November 22, 2013
Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infectionR Chris Rathbun, Staci M Lockhart, Misty M Miller, et al.
Infection and Drug Resistance|March 4, 2015
The role of dolutegravir in the management of HIV infectionMisty M Miller, Michelle D Liedtke, Staci M Lockhart, et al.
Infection and Drug Resistance|March 28, 2014
Long-term efficacy and safety of raltegravir in the management of HIV infectionMichelle D Liedtke, C Ryan Tomlin, Staci M Lockhart, et al.
Pharmacotherapy|March 9, 2017
Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical PharmacySpencer H Durham, Melissa E Badowski, Michelle D Liedtke, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Safety|January 26, 2010
Drug interactions with antiretrovirals and warfarinMichelle D Liedtke, R Chris Rathbun
Pharmaceutics|December 7, 2013
Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for managementR Chris Rathbun, Michelle D Liedtke
The Annals of Pharmacotherapy|February 7, 2009
Warfarin-antiretroviral interactionsMichelle D Liedtke, R Chris Rathbun
The Annals of Pharmacotherapy|November 2, 2012
A probable interaction between warfarin and the antiretroviral TRIO study regimenMichelle D Liedtke, Amulya Vanguri, R Chris Rathbun
The Annals of Pharmacotherapy|February 19, 2004
Anticonvulsant and antiretroviral interactionsMichelle D Liedtke, Staci M Lockhart, R Chris Rathbun
International Journal of STD & AIDS|June 21, 2017
Evaluation of the concurrent use of dolutegravir and metformin in human immunodeficiency virus-infected patientsAnne Masich, Melissa E Badowski, Michelle D Liedtke, et al.
The Annals of Pharmacotherapy|November 22, 2013
Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infectionR Chris Rathbun, Staci M Lockhart, Misty M Miller, et al.
Infection and Drug Resistance|March 4, 2015
The role of dolutegravir in the management of HIV infectionMisty M Miller, Michelle D Liedtke, Staci M Lockhart, et al.
Infection and Drug Resistance|March 28, 2014
Long-term efficacy and safety of raltegravir in the management of HIV infectionMichelle D Liedtke, C Ryan Tomlin, Staci M Lockhart, et al.
Pharmacotherapy|March 9, 2017
Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical PharmacySpencer H Durham, Melissa E Badowski, Michelle D Liedtke, et al.
Pageof 2